Skip to main navigation
Skip to search
Skip to main content
Sort by
Keyphrases
Gonadotoxic Treatment
100%
Transgender Adolescents
100%
Sperm Cryopreservation
100%
Adolescents with Cancer
75%
Fertility Preservation
50%
Semen Quality Parameters
50%
Medical Center
25%
Demographic Data
25%
Female-to-male
25%
Testosterone
25%
Medical Records
25%
Motility
25%
Female Adolescents
25%
Counseling
25%
Hormone Levels
25%
Luteinizing Hormone
25%
Estradiol
25%
Semen Parameters
25%
Chi-square Analysis
25%
Follicle-stimulating Hormone
25%
University of Texas
25%
Normal Adults
25%
Treatment Impact
25%
Treatment Delay
25%
Total Count
25%
Adolescent Males
25%
Reproductive Medicine
25%
Future Fertility
25%
Azoospermia
25%
Tanner Stage
25%
Knowledge Deficit
25%
March 2015
25%
Sperm Parameters
25%
Gender-affirming Hormone Therapy
25%
Transgender Male
25%
Female Youth
25%
Differences between Groups
25%
Statistically Significant Difference
25%
Transgender Population
25%
Gonadotoxic Chemotherapy
25%
Nursing and Health Professions
Cryopreservation
100%
Transgender
100%
Youth
100%
Malignant Neoplasm
62%
Fertility Preservation
25%
Sperm Quality
25%
Chi Square Test
12%
Medical Record
12%
Student T Test
12%
Counseling
12%
Hormonal Therapy
12%
Hormone Determination
12%
Diethylstilbestrol
12%
Luteinizing Hormone
12%
Therapy Delay
12%
Follitropin
12%
Testosterone
12%
Chemotherapy
12%
Reproductive Medicine
12%
Reproduction
12%
Azoospermia
12%
Medicine and Dentistry
Adolescence
100%
Cryopreservation
100%
Transgender
100%
Malignant Neoplasm
62%
Fertility Preservation
25%
fertility
25%
Student T Test
12%
Hormone Determination
12%
Medical Record
12%
Chi Square Test
12%
Diethylstilbestrol
12%
Luteinizing Hormone
12%
Follitropin
12%
Counseling
12%
Hormone Therapy
12%
Testosterone
12%
Azoospermia
12%
Therapy Delay
12%
Chemotherapy
12%
Reproductive Medicine
12%